NO981469D0 - Ditiolanderivater, deres fremstilling og deres terapeutiske effekt - Google Patents
Ditiolanderivater, deres fremstilling og deres terapeutiske effektInfo
- Publication number
- NO981469D0 NO981469D0 NO981469A NO981469A NO981469D0 NO 981469 D0 NO981469 D0 NO 981469D0 NO 981469 A NO981469 A NO 981469A NO 981469 A NO981469 A NO 981469A NO 981469 D0 NO981469 D0 NO 981469D0
- Authority
- NO
- Norway
- Prior art keywords
- dithioland
- derivatives
- preparation
- therapeutic effect
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8374997 | 1997-04-02 | ||
JP883798 | 1998-01-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO981469D0 true NO981469D0 (no) | 1998-04-01 |
NO981469L NO981469L (no) | 1998-10-05 |
Family
ID=26343433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO981469A NO981469L (no) | 1997-04-02 | 1998-04-01 | Ditiolanderivater, deres fremstilling og deres terapeutiske effekt |
Country Status (24)
Country | Link |
---|---|
US (2) | US6013663A (no) |
EP (2) | EP1070710A3 (no) |
KR (1) | KR19980081044A (no) |
CN (1) | CN1208035A (no) |
AR (1) | AR012315A1 (no) |
AT (1) | ATE221525T1 (no) |
AU (1) | AU728488B2 (no) |
BR (1) | BR9806413A (no) |
CA (1) | CA2233682A1 (no) |
CZ (1) | CZ96798A3 (no) |
DE (1) | DE69806831T2 (no) |
DK (1) | DK0869126T3 (no) |
ES (1) | ES2179427T3 (no) |
HK (1) | HK1015765A1 (no) |
HU (1) | HUP9800743A3 (no) |
ID (1) | ID19824A (no) |
IL (1) | IL123887A0 (no) |
NO (1) | NO981469L (no) |
NZ (1) | NZ330092A (no) |
PL (1) | PL325691A1 (no) |
PT (1) | PT869126E (no) |
RU (2) | RU2165932C2 (no) |
TR (2) | TR199800602A2 (no) |
TW (1) | TW508354B (no) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6090842A (en) * | 1998-03-10 | 2000-07-18 | The Regents Of The University Of California | Lipoic acid analogs |
WO2000007582A2 (en) * | 1998-08-06 | 2000-02-17 | Warner-Lambert Company | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts |
JP4728481B2 (ja) | 1998-10-26 | 2011-07-20 | ザ リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | リポ酸誘導体および疾患の治療におけるそれら誘導体の使用 |
US6900338B1 (en) | 1998-11-25 | 2005-05-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Scavenger compounds |
FR2787109B1 (fr) * | 1998-12-15 | 2001-01-19 | Adir | Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6204288B1 (en) | 1999-03-08 | 2001-03-20 | The University Of Mississippi | 1,2-dithiolane derivatives |
AR042572A1 (es) * | 1999-04-02 | 2005-06-29 | Sod Conseils Rech Applic | Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos |
FR2791677B1 (fr) * | 1999-04-02 | 2001-08-17 | Sod Conseils Rech Applic | Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
FR2805537A1 (fr) * | 2000-02-24 | 2001-08-31 | Sod Conseils Rech Applic | Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
IT1312569B1 (it) * | 1999-05-21 | 2002-04-22 | Raffaele Ansovini | Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv. |
GB9913226D0 (en) * | 1999-06-07 | 1999-08-04 | Novartis Ag | Organic compounds |
DE19941217A1 (de) * | 1999-08-30 | 2001-03-15 | Asta Medica Ag | Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben |
US6369098B1 (en) | 1999-10-05 | 2002-04-09 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
US6664287B2 (en) * | 2000-03-15 | 2003-12-16 | Bethesda Pharmaceuticals, Inc. | Antioxidants |
FR2806409B1 (fr) * | 2000-03-16 | 2002-04-19 | Sod Conseils Rech Applic | Nouveaux derives heterocycliques de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
WO2001068643A2 (fr) | 2000-03-16 | 2001-09-20 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Nouveaux derives heterocycliques ou benzeniques de l'acide lipoique, leur preparation et leur application a titre de medicaments |
US6387945B2 (en) * | 2000-04-11 | 2002-05-14 | The Regents Of The University Of California | Lipoic acid analogs |
EP1172110A3 (de) * | 2000-07-07 | 2003-09-17 | Basf Aktiengesellschaft | Verwendung von Liponsäure zur Verbesserung der Bioverfügbarkeit von Mineralsalzen |
US8795706B2 (en) | 2000-08-16 | 2014-08-05 | Encore Health, Llc | Methods of treating ocular diseases using derivatives of lipoic acid |
US8697109B2 (en) | 2000-08-16 | 2014-04-15 | Encore Health, Llc | Caged mercaptan and seleno-mercaptan compounds and methods of using them |
US7935332B2 (en) | 2000-08-16 | 2011-05-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
US6495170B1 (en) * | 2000-08-16 | 2002-12-17 | N. V. Nutricia | Method of increasing the presence of glutathione in cells |
US20050112113A1 (en) * | 2000-08-16 | 2005-05-26 | Till Jonathan S. | Presbyopia treatment by lens alteration |
US7914815B2 (en) * | 2000-08-16 | 2011-03-29 | Encore Health, Llc | Method for delivery of pharmaceuticals for treating or preventing presbyopia |
US8647612B2 (en) * | 2008-03-05 | 2014-02-11 | Encore Health, Llc | Dithiol compounds, derivatives, and treatment of presbyopia |
IT1319196B1 (it) * | 2000-10-10 | 2003-09-26 | Laboratorio Chimico Int Spa | Sintesi dell'acido r(+)alfa-lipoico. |
IT1319195B1 (it) * | 2000-10-10 | 2003-09-26 | Laboratorio Chimico Int Spa | Processo per la produzione dell'acido r(+)alfa-lipoico. |
DE10201464B4 (de) * | 2002-01-16 | 2005-06-16 | Viatris Gmbh & Co. Kg | Verfahren zur Herstellung reiner Thioctsäure |
EP1476440A4 (en) * | 2002-02-22 | 2005-06-01 | Albany College Of Pharmacy | METHODS AND COMPOUNDS USEFUL IN INHIBITION BY RADICAL AND / OR OXIDIZING AGGRESSION AND IN THE TREATMENT AND PREVENTION OF DISEASE |
AU2003208767A1 (en) * | 2002-03-05 | 2003-09-16 | Universitaet Ulm | Dithiolane derivatives for immobilizing biomolecules on noble metals and semiconductors |
JP3970811B2 (ja) | 2002-09-09 | 2007-09-05 | 独立行政法人科学技術振興機構 | リンカー化合物及びリガンド、並びにそれらの製造方法 |
US20040229815A1 (en) * | 2003-01-03 | 2004-11-18 | Nagasawa Herbert T. | Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug |
US7202270B2 (en) * | 2003-06-20 | 2007-04-10 | Sami Labs Limited | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses |
US7462526B2 (en) * | 2003-11-18 | 2008-12-09 | Silicon Genesis Corporation | Method for fabricating semiconductor devices using strained silicon bearing material |
US20080102119A1 (en) * | 2006-11-01 | 2008-05-01 | Medtronic, Inc. | Osmotic pump apparatus and associated methods |
US7389347B2 (en) * | 2004-04-16 | 2008-06-17 | International Business Machines Corporation | Active probing for real-time diagnosis |
AU2006209079A1 (en) * | 2005-01-27 | 2006-08-03 | Alma Mater Studiorum-Universita' Di Bologna | Organic compounds useful for the treatment of Alzheimer's disease, their use and method of preparation |
CN101282740A (zh) * | 2005-09-01 | 2008-10-08 | 阿雷斯贸易股份有限公司 | 视神经炎的治疗 |
CN100436444C (zh) * | 2006-07-29 | 2008-11-26 | 常熟富士莱医药化工有限公司 | 硫辛酰胺合成工艺 |
WO2008067403A2 (en) * | 2006-11-28 | 2008-06-05 | Encore Health Llc | Presbyopia treatment by lens alteration |
US9239329B2 (en) | 2006-12-18 | 2016-01-19 | Japan Science And Technology Agency | Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods |
US8318795B2 (en) * | 2007-03-01 | 2012-11-27 | Cedars-Sinai Medical Center | Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof |
WO2009014343A2 (en) * | 2007-07-20 | 2009-01-29 | Biogenics, Inc. | Ascorbic acid derivatives having alpha-lipoyl groups and process for preparing the same |
KR101056037B1 (ko) * | 2007-07-20 | 2011-08-10 | (주)바이오제닉스 | 알파-리포일기 함유 아스코르브산 유도체 및 그의 제조방법 |
KR101056039B1 (ko) * | 2007-07-20 | 2011-08-10 | (주)바이오제닉스 | 알파-리포일기 함유 아스코르브산 유도체 및 그의 제조방법 |
DE102007038849A1 (de) | 2007-08-16 | 2009-02-19 | Adscil Gmbh | Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie |
US8102027B2 (en) * | 2007-08-21 | 2012-01-24 | Broadcom Corporation | IC package sacrificial structures for crack propagation confinement |
US9028874B2 (en) * | 2008-01-03 | 2015-05-12 | Cedars-Sinai Medical Center | Antioxidant nanosphere comprising [1,2]-dithiolane moieties |
CN101497600B (zh) * | 2008-01-29 | 2012-02-08 | 首都医科大学 | 2,4,5-三取代-1,3-二硫戊环、其合成方法、其应用 |
WO2009111635A2 (en) | 2008-03-05 | 2009-09-11 | Encore Health, Llc | Dithiol compounds, derivatives, and uses therefor |
US9044439B2 (en) * | 2008-03-05 | 2015-06-02 | Encore Health, Llc | Low dose lipoic and pharmaceutical compositions and methods |
WO2009138437A1 (en) * | 2008-05-13 | 2009-11-19 | Genmedica Therapeutics Sl | Salicylate conjugates useful for treating metabolic disorders |
WO2009148698A1 (en) | 2008-06-02 | 2009-12-10 | Cedars-Sinai Medical Center | Nanometer-sized prodrugs of nsaids |
FR2936153B1 (fr) * | 2008-09-24 | 2010-10-08 | Oreal | Utilisations de composes dithiolanes pour la photoprotection de la peau ; nouveaux composes dithiolanes ; compositions les contenant. |
FR2936146B1 (fr) * | 2008-09-24 | 2010-10-08 | Oreal | Utilisations de composes dithiolanes pour la photoprotection de la peau ; nouveaux composes dithiolanes ; compositions les contenant. |
FR2936706B1 (fr) * | 2008-10-08 | 2010-12-17 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane |
FR2937035B1 (fr) * | 2008-10-10 | 2010-12-31 | Oreal | Composes dithiolanes ; compositions les contenant ; utilisations pour la photoprotection de la peau |
KR101493125B1 (ko) | 2008-11-24 | 2015-02-12 | 세다르스-신나이 메디칼 센터 | 항산화성 캠토테신 유도체 및 이들의 항산화성 항종양성 나노구체 |
FR2939042B1 (fr) | 2008-11-28 | 2010-11-26 | Oreal | PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES. |
CN101787013B (zh) * | 2009-01-22 | 2013-04-24 | 杭州民生药业有限公司 | 硫辛酰胺系列衍生物、制备方法及所述衍生物的制药用途 |
EP2408441A1 (en) * | 2009-03-16 | 2012-01-25 | Genmedica Therapeutics SL | Combination therapies for treating metabolic disorders |
EP2408443A1 (en) * | 2009-03-16 | 2012-01-25 | Genmedica Therapeutics SL | Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
US7928067B2 (en) | 2009-05-14 | 2011-04-19 | Ischemix Llc | Compositions and methods for treating ischemia and ischemia-reperfusion injury |
WO2010147962A1 (en) | 2009-06-15 | 2010-12-23 | Encore Health, Llc | Choline esters |
FR2952300B1 (fr) * | 2009-11-09 | 2012-05-11 | Oreal | Nouveaux colorants fluorescents a motif heterocyclique disulfure, composition de teinture les comprenant et procede de coloration des fibres keratiniques humaines a partir de ces colorants |
JP2014502264A (ja) * | 2010-11-18 | 2014-01-30 | イスケミックス エルエルシー | リポイル化合物および虚血性傷害を治療するためのその使用 |
US8466197B2 (en) | 2010-12-14 | 2013-06-18 | Genmedica Therapeutics Sl | Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
DK2920196T3 (da) | 2012-11-15 | 2021-06-14 | Univ Brandeis | Binding af cysteinrester under anvendelse af cykliske disulfider |
EP3110800A1 (en) * | 2014-02-27 | 2017-01-04 | Consorzio Interuniversitario Nazionale Per La Scienza E La Tecnologia Dei Materiali (INSTM) | Novel compounds having anti-allodynic and antihyperalgesic activity |
KR20160145558A (ko) | 2014-03-03 | 2016-12-20 | 앙코르 비전, 인코포레이티드 | 리포산 콜린 에스테르 조성물 및 사용 방법 |
WO2016126662A1 (en) * | 2015-02-03 | 2016-08-11 | Kardiatonos, Inc. | Compounds for the prevention and treatment of vascular disease |
WO2017031226A1 (en) | 2015-08-18 | 2017-02-23 | Brandeis University | Tethering cysteine residues using cyclic disulfides |
ES2906178T3 (es) * | 2016-03-14 | 2022-04-13 | Neostrata Company Inc | Aminoácido o péptido N-lipoico, derivados y sus usos |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
CN106866620B (zh) * | 2017-03-30 | 2019-09-20 | 山东齐都药业有限公司 | 一种硫辛酸氧化杂质的制备方法 |
JP7203756B2 (ja) | 2017-04-25 | 2023-01-13 | イスケミックス エルエルシー | 外傷性脳傷害を治療するための組成物および方法 |
CN113710320A (zh) * | 2019-04-17 | 2021-11-26 | 参天制药株式会社 | 硫辛酸前药 |
CN110294738A (zh) * | 2019-07-22 | 2019-10-01 | 通化师范学院 | 硫辛酸衍生物及其制备方法和用途 |
WO2024101918A1 (ko) * | 2022-11-11 | 2024-05-16 | 주식회사 메디치바이오 | 리포-하이드록삼산 유도체 및 이의 약학적 용도 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1210892B (de) * | 1959-10-13 | 1966-02-17 | Fujisawa Pharmaceutical Co | Verfahren zur Herstellung von 5[3-(1, 2-Dithiacylopentyl)]-pentan-saeureamiden |
DE1210893B (de) * | 1960-06-17 | 1966-02-17 | Fujisawa Pharmaceutical Co | Verfahren zur Herstellung von 6, 8-Dithiooctansaeureamiden |
FR1294134A (fr) * | 1960-12-27 | 1962-05-26 | Takeda Pharmaceutical Ind | Procédé de préparation d'alpha-lipoamides |
CH656382A5 (de) * | 1983-10-24 | 1986-06-30 | Sandoz Ag | Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung. |
JPH0673005B2 (ja) * | 1985-01-24 | 1994-09-14 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料 |
JPH0670133B2 (ja) * | 1985-08-29 | 1994-09-07 | 出光興産株式会社 | リポアミド膜およびその製造法 |
JP2553090B2 (ja) | 1987-07-21 | 1996-11-13 | 帝人株式会社 | 組織グルタチオンレベル向上剤 |
FR2653334B1 (fr) * | 1989-10-19 | 1991-12-20 | Erphar Ste Civile | Preparation cosmetique de bronzage. |
DE4000397A1 (de) * | 1990-01-09 | 1991-07-11 | Hoechst Ag | Lipidselektive antioxidantien sowie deren herstellung und verwendung |
IT1252865B (it) * | 1991-12-31 | 1995-06-28 | Lifegroup Spa | N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni |
IT1256178B (it) | 1992-11-30 | 1995-11-29 | Lorenzo Ferrari | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
FR2707983A1 (fr) * | 1993-07-21 | 1995-01-27 | Pf Medicament | Nouveaux dérivés de l'acide lipoïque et dihydrolipoïque, leur préparation et leur application en thérapeutique humaine. |
DE4327462A1 (de) * | 1993-08-16 | 1995-02-23 | Carl Heinrich Dr Weischer | Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen |
DE4343593C2 (de) * | 1993-12-21 | 1998-05-20 | Asta Medica Ag | Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz |
JP2000515111A (ja) * | 1995-12-14 | 2000-11-14 | ボリソビチ バラツォフスキィ,マルク | サイトカインおよび造血因子の内因性産生増強因子とその利用方法 |
-
1998
- 1998-03-30 AU AU59702/98A patent/AU728488B2/en not_active Ceased
- 1998-03-30 CZ CZ98967A patent/CZ96798A3/cs unknown
- 1998-03-30 IL IL12388798A patent/IL123887A0/xx unknown
- 1998-03-31 US US09/052,095 patent/US6013663A/en not_active Expired - Fee Related
- 1998-03-31 NZ NZ330092A patent/NZ330092A/xx unknown
- 1998-04-01 RU RU98106623/04A patent/RU2165932C2/ru not_active IP Right Cessation
- 1998-04-01 CA CA002233682A patent/CA2233682A1/en not_active Abandoned
- 1998-04-01 AT AT98302532T patent/ATE221525T1/de not_active IP Right Cessation
- 1998-04-01 DK DK98302532T patent/DK0869126T3/da active
- 1998-04-01 HU HU9800743A patent/HUP9800743A3/hu unknown
- 1998-04-01 RU RU99119545/04A patent/RU2169731C2/ru not_active IP Right Cessation
- 1998-04-01 PT PT98302532T patent/PT869126E/pt unknown
- 1998-04-01 TR TR1998/00602A patent/TR199800602A2/xx unknown
- 1998-04-01 DE DE69806831T patent/DE69806831T2/de not_active Expired - Fee Related
- 1998-04-01 EP EP00122586A patent/EP1070710A3/en not_active Withdrawn
- 1998-04-01 ES ES98302532T patent/ES2179427T3/es not_active Expired - Lifetime
- 1998-04-01 NO NO981469A patent/NO981469L/no not_active Application Discontinuation
- 1998-04-01 EP EP98302532A patent/EP0869126B1/en not_active Expired - Lifetime
- 1998-04-02 PL PL98325691A patent/PL325691A1/xx unknown
- 1998-04-02 KR KR1019980011699A patent/KR19980081044A/ko not_active Application Discontinuation
- 1998-04-02 BR BR9806413-4A patent/BR9806413A/pt not_active IP Right Cessation
- 1998-04-02 TW TW087104965A patent/TW508354B/zh active
- 1998-04-02 ID IDP980497A patent/ID19824A/id unknown
- 1998-04-02 AR ARP980101513A patent/AR012315A1/es unknown
- 1998-04-02 CN CN98102916A patent/CN1208035A/zh active Pending
-
1999
- 1999-02-15 HK HK99100665A patent/HK1015765A1/xx not_active IP Right Cessation
- 1999-07-15 US US09/354,006 patent/US6313164B1/en not_active Expired - Fee Related
-
2002
- 2002-12-18 TR TR2002/02678A patent/TR200202678A2/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0869126T3 (da) | Dithiolanderivater, deres fremstilling og deres terapeutiske virkning | |
NO980720D0 (no) | Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling | |
DK1019358T3 (da) | 3,3-diarylpropylaminer, deres anvendelse og fremstilling | |
DK1161434T3 (da) | Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse | |
DK0871656T3 (da) | Dolastatinderivater, deres fremstilling og anvendelse | |
NO943682D0 (no) | Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse | |
NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
DK1073672T3 (da) | Antipicornavirale forbindelser, deres fremstilling og anvendelse | |
NO20003773D0 (no) | Syklobutenderivater, deres fremstilling og deres terapeutiske anvendelser | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO975020D0 (no) | Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi | |
NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
NO962477D0 (no) | Benzamidderivater, deres fremstilling og deres terapautiske anvendelse | |
NO20001934D0 (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
DK0835254T3 (da) | Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse | |
NO20000066D0 (no) | 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse | |
NO955242D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse | |
NO984921D0 (no) | Tienopyridinderivater og deres anvendelse | |
NO980471D0 (no) | Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav | |
NO20012802D0 (no) | Benzofuranderivater, deres fremstilling og anvendelse | |
NO972821D0 (no) | 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse | |
NO20001782D0 (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO996156L (no) | Substituerte cykloheptener, deres fremstilling og anvendelse | |
NO982549D0 (no) | 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav | |
NO950560L (no) | Piperazinderivater, deres fremstilling og terapautiske anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |